Syngene Amgen Research and Development Centre (SARC), Syngene International Ltd, Biocon Park, Bangalore,560099, India.
Syngene Amgen Research and Development Centre (SARC), Syngene International Ltd, Biocon Park, Bangalore,560099, India.
J Chromatogr A. 2018 Feb 23;1538:108-111. doi: 10.1016/j.chroma.2018.01.035.
A normal phase liquid chromatography method was developed for the separation and detection of eight stereoisomers of the key intermediate, CORE + OMe, having three chiral centers. The stereochemistry of this intermediate dictates the stereochemistry of the active pharmaceutical ingredient generated by an additional six synthetic steps. Multiple columns and mobile phases were screened during the development based on a platform approach. The use of dichloromethane as mobile phase additive and adjustment of flow rate and column temperature contributed in achieving resolution of these eight stereoisomers. The separation and detection of these stereoisomers was achieved using a Chiralcel OD-H, 4.6 × 250 mm, 5 μm d column with heptane: ethanol: dichloromethane in a ratio of 95:3:2 (v:v:v) as mobile phase at a flow rate of 0.7 mL/min. UV detection was carried out at 245 nm and the column temperature was maintained at 15 °C. The analytical method was phase appropriately validated. The limit of detection and limit of quantification were found to be 0.035 and 0.07 μg, respectively. The newly developed method has been implemented for routine utilization to monitor the chiral control during process development and used as the quality control method for chiral purity of the desired compound.
建立了一种正相液相色谱法,用于分离和检测具有三个手性中心的关键中间体 CORE+OMe 的 8 种对映异构体。该中间体的立体化学决定了通过另外六个合成步骤生成的活性药物成分的立体化学。在开发过程中,根据平台方法筛选了多种柱和流动相。使用二氯甲烷作为流动相添加剂以及调整流速和柱温有助于实现这 8 种对映异构体的分离。使用 Chiralcel OD-H,4.6×250mm,5μm d 柱,以正己烷:乙醇:二氯甲烷的比例为 95:3:2(v:v:v)作为流动相,流速为 0.7mL/min,实现了这些对映异构体的分离和检测。在 245nm 处进行紫外检测,柱温保持在 15°C。对分析方法进行了适当的验证。检测限和定量限分别为 0.035 和 0.07μg。新开发的方法已用于常规监测工艺开发过程中的手性控制,并用作所需化合物手性纯度的质量控制方法。